Implantable Defibrillators Market by Product Type & Geography - Forecast to Grow at a CAGR of 4.9% by 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Implantable Defibrillators Market by Product Type and Geography - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering.

Implantable Defibrillators Market Report, forecasts that the global market was valued at $6,006 million in 2015 and is expected to garner $8,449 million by 2022, registering a CAGR of 4.9% during the forecast period 2016-2022. Transvenous implantable cardioverter defibrillators (T-ICDs) segment accounted for more than half of the global market in 2015.

Implantable defibrillators are used to prevent sudden death in patients who sustained atrial fibrillation or ventricular tachycardia. These devices are implanted inside the patients body and are able to perform defibrillation, pacing of the heart, and cardioversion. The irregular heart rhythms that require ICD implant include bradycardia, ventricular tachycardia, and ventricular fibrillation.

Surge in geriatric population; increase in prevalence of chronic health conditions such as cardiac arrhythmia, ventricular fibrillation, and pulseless ventricular tachycardia, growth in preference for S-ICDs, and rise in awareness among patients about implantable defibrillators are expected to drive the market growth. However, lack of awareness towards the availability of implantable defibrillator to prevent sudden cardiac arrest (SCA) and adoption of these devices in low- and middle-income economies are projected to hamper the market growth.

Companies Mentioned

  • Boston Scientific Corporation
  • LivaNova PLC Company
  • Imricor Medical Systems
  • MicroPort Scientific Corporation
  • Mayo Clinic US
  • Medtronic Plc
  • MRI Interventions, Inc.
  • St. Jude Medical, Inc.
  • Biotronik Se & Co.KG
  • Sorin Group

Key Topics Covered:

CHAPTER 1. INTRODUCTION

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. MARKET OVERVIEW

CHAPTER 4. IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE

CHAPTER 5. IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION

CHAPTER 6. COMPANY PROFILES

For more information about this report visit http://www.researchandmarkets.com/research/qpl7ts/implantable

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices